Literature DB >> 7739027

Killing of methicillin-resistant Staphylococcus aureus by low-power laser light.

M Wilson1, C Yianni.   

Abstract

The purpose of this study was to determine whether a methicillin-resistant strain of Staphylococcus aureus (MRSA) could be sensitised by toluidine blue O (TBO) to killing by light from a low-power helium/neon (HeNe) laser. Suspensions containing c. 10(10) cfu of MRSA were irradiated with light from a 35 mW HeNe laser (energy dose: 0.5-2.1 J) in the presence of TBO (1.6-12.5 micrograms/ml) and the survivors were enumerated. The kills attained depended on both the light energy dose and concentration of TBO employed. A 4.47 log10 reduction in the viable count was achieved with a TBO concentration of 12.5 micrograms/ml and a light dose of 2.1 J (energy density 43 J/cm2). MRSA were susceptible to killing by the laser light within 30 s of exposure to the TBO. The results of this study have demonstrated that MRSA can be rapidly sensitised by TBO to killing by HeNe laser light and that killing depends on the light energy dose and sensitiser concentration.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7739027     DOI: 10.1099/00222615-42-1-62

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  19 in total

1.  Photodynamic therapy: a new antimicrobial approach to infectious disease?

Authors:  Michael R Hamblin; Tayyaba Hasan
Journal:  Photochem Photobiol Sci       Date:  2004-02-12       Impact factor: 3.982

2.  Targeted photodynamic therapy of established soft-tissue infections in mice.

Authors:  Faten Gad; Touqir Zahra; Kevin P Francis; Tayyaba Hasan; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2004-02-11       Impact factor: 3.982

3.  Susceptibility of Staphylococcus aureus to porphyrin-mediated photodynamic antimicrobial chemotherapy: an in vitro study.

Authors:  Mariana M Gois; Christina Kurachi; E J B Santana; E G O Mima; D M P Spolidório; José Eduardo Pelizon Pelino; Vanderlei Salvador Bagnato
Journal:  Lasers Med Sci       Date:  2009-07-08       Impact factor: 3.161

4.  Monitoring photodynamic therapy of localized infections by bioluminescence imaging of genetically engineered bacteria.

Authors:  Tatiana N Demidova; Faten Gad; Touqir Zahra; Kevin P Francis; Michael R Hamblin
Journal:  J Photochem Photobiol B       Date:  2005-10-03       Impact factor: 6.252

5.  Assessment of rose bengal versus riboflavin photodynamic therapy for inhibition of fungal keratitis isolates.

Authors:  Alejandro Arboleda; Darlene Miller; Florence Cabot; Mukesh Taneja; Mariela C Aguilar; Karam Alawa; Guillermo Amescua; Sonia H Yoo; Jean-Marie Parel
Journal:  Am J Ophthalmol       Date:  2014-04-29       Impact factor: 5.258

6.  Laser light combined with a photosensitizer may eliminate methicillin-resistant strains of Staphylococcus aureus.

Authors:  Khalil I Hajim; Dhuha S Salih; Yasemin Z Rassam
Journal:  Lasers Med Sci       Date:  2010-06-16       Impact factor: 3.161

Review 7.  Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants.

Authors:  Adelaide Almeida; Angela Cunha; Newton C M Gomes; Eliana Alves; Liliana Costa; Maria A F Faustino
Journal:  Mar Drugs       Date:  2009-07-30       Impact factor: 5.118

8.  Effects of low intensity laser irradiation during healing of infected skin wounds in the rat.

Authors:  Ethne L Nussbaum; Facundo Las Heras; Kenneth P H Pritzker; Tony Mazzulli; Lothar Lilge
Journal:  Photonics Lasers Med       Date:  2014-02-01

9.  Histological evaluation of the safety of toluidine blue-mediated photosensitization to periodontal tissues in mice.

Authors:  X L Luan; Y L Qin; L J Bi; C Y Hu; Z G Zhang; J Lin; C N Zhou
Journal:  Lasers Med Sci       Date:  2008-02-01       Impact factor: 3.161

10.  Rose Bengal-decorated silica nanoparticles as photosensitizers for inactivation of gram-positive bacteria.

Authors:  Yanyan Guo; Snezna Rogelj; Peng Zhang
Journal:  Nanotechnology       Date:  2010-01-11       Impact factor: 3.874

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.